{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:11:40Z","timestamp":1770063100294,"version":"3.49.0"},"reference-count":47,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries Ltd","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1080\/14737175.2025.2602188","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:15:28Z","timestamp":1766132128000},"page":"197-205","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Physician experience and perceptions of tetrabenazine for the treatment of tardive dyskinesia and Huntington\u2019s chorea: a survey of neurologists and psychiatrists"],"prefix":"10.1080","volume":"26","author":[{"given":"Victor W","family":"Sung","sequence":"first","affiliation":[{"name":"University of Alabama at Birmingham","place":["Birmingham, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel O.","family":"Claassen","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center","place":["Nashville, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinat","family":"Ribalov","sequence":"additional","affiliation":[{"name":"Teva Pharmaceutical Industries Ltd","place":["Tel Aviv, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayelet","family":"Yaari","sequence":"additional","affiliation":[{"name":"Teva Pharmaceutical Industries Ltd","place":["Tel Aviv, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Guillaume","sequence":"additional","affiliation":[{"name":"Oracle Life Sciences","place":["Paris, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perrine","family":"Le Calv\u00e9","sequence":"additional","affiliation":[{"name":"Oracle Life Sciences","place":["Paris, France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviva","family":"Peyser Levin","sequence":"additional","affiliation":[{"name":"Teva Pharmaceutical Industries Ltd","place":["Tel Aviv, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manho","family":"Kim","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital, Seoul National University College of Medicine","place":["Seoul, Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Gurevich","sequence":"additional","affiliation":[{"name":"Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2010.00134.x"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000563"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2019.1613965"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2019.02.003"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1002-0829.2013.03.002"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.5"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13413"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16r10832"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.7916\/D8MS3R8C"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/nmt-2016-0008"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000443738"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-210500"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-019-02269-8"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001201"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852917000542"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/1359105312438109"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-018-0312-x"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.S310605"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.36469\/001c.24620"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1260"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1403899"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2011.9.1.1"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.3233\/BEN-2012-120268"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0874-x"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2015.1025383"},{"issue":"12","key":"e_1_3_8_28_1","first-page":"690","article-title":"Tetrabenazine (Xenazine), an FDA-approved treatment option for Huntington\u2019s disease-related chorea","volume":"33","author":"Yero T","year":"2008","unstructured":"Yero T, Rey JA. Tetrabenazine (Xenazine), an FDA-approved treatment option for Huntington\u2019s disease-related chorea. P T. 2008;33(12):690\u2013694.","journal-title":"P T"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000326"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.06.010"},{"key":"e_1_3_8_31_1","unstructured":"iNova Pharmaceuticals (Aust) Pty Ltd. Tetrabenazine. tablets. 2019."},{"key":"e_1_3_8_32_1","unstructured":"Neopharm Ltd. Xenazine. \u00ae (tetrabenazine) tablets. 2023. Deerfield (IL)."},{"key":"e_1_3_8_33_1","unstructured":"Korean Orphan & Essential Drug Center. Center supply drug information - tetrabenazine. Available from: https:\/\/www.kodc.or.kr\/drugInfo\/664000060"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S6430"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1435518"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12754"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852918001219"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00710"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2025.10047"},{"key":"e_1_3_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2020.01.004"},{"key":"e_1_3_8_41_1","unstructured":"Biosciences N. Neurocrine Biosciences announces FDA approval of INGREZZA\u00ae (valbenazine) capsules for the treatment of chorea associated with Huntington\u2019s disease. 2023 Available from: https:\/\/neurocrine.gcs-web.com\/news-releases\/news-release-details\/neurocrine-biosciences-announces-fda-approval-ingrezzar"},{"key":"e_1_3_8_42_1","unstructured":"Teva Neuroscience LLC. Austedo. \u00ae (deutetrabenazine) tablets. 2025. Parsippany (NJ)."},{"key":"e_1_3_8_43_1","unstructured":"South Korea Ministry of Food and Drug Safety. 2020 drug approval report. Kim Ganglip 2021."},{"key":"e_1_3_8_44_1","unstructured":"Teva Pharmaceutical Industries Ltd. Austedo. 2025."},{"key":"e_1_3_8_45_1","unstructured":"Teva Pharma Australia Pty Limited. Austedo. \u00ae (deutetrabenazine) modified release tablets. 2021."},{"key":"e_1_3_8_46_1","unstructured":"Teva Farmac\u00eautica Ltda. Austedo. (deutetrabenazina) comprimido revestido. 2021."},{"key":"e_1_3_8_47_1","unstructured":"Laboratorio Chile. Austedo. Comprimidos recubiertos. 2022."},{"key":"e_1_3_8_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/0163278718809844"},{"key":"e_1_3_8_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-015-0016-z"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2025.2602188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:02:48Z","timestamp":1770022968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2025.2602188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1080\/14737175.2025.2602188"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2025.2602188","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}